MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-06-2026
Repro Med Systems Total Current Liabilities 2011-2026 | KRMD
Annual Total Current Liabilities Repro Med Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.19 M | 7.2 M | 4.45 M | 6.96 M | 4.79 M | 3.67 M | 2.41 M | 1.58 M | 1.59 M | 1.11 M | 692 K | 772 K | 525 K | 559 K | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.19 M | 525 K | 3.18 M |
Total Current Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
1.11 B | $ 60.37 | -0.02 % | $ 12 B |  USA |
 |
Atrion Corporation
ATRI
|
12.6 K | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
87.5 M | - | - | $ 1.75 B | USA |
 |
ICU Medical
ICUI
|
499 M | $ 121.43 | -1.27 % | $ 2.99 B | USA |
 |
iRhythm Technologies
IRTC
|
152 M | $ 115.62 | 1.27 % | $ 3.7 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
1.53 M | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
2.01 B | $ 427.32 | -0.17 % | $ 153 B | USA |
 |
LeMaitre Vascular
LMAT
|
36.3 M | $ 98.04 | -1.47 % | $ 2.22 B | USA |
 |
Masimo Corporation
MASI
|
618 M | $ 178.39 | 0.02 % | $ 9.51 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
63.2 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
179 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
11.8 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
952 M | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
8.64 M | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
853 M | $ 23.67 | -0.75 % | $ 3.98 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.85 B | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
11.3 M | $ 6.07 | -5.6 % | $ 51.5 K | USA |
 |
Haemonetics Corporation
HAE
|
578 M | $ 57.22 | 0.18 % | $ 2.88 B | USA |
 |
Isoray
ISR
|
28.7 M | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
74 M | $ 142.48 | 0.23 % | $ 6.9 B | USA |
 |
STAAR Surgical Company
STAA
|
68.5 M | $ 32.92 | 2.84 % | $ 1.63 B | USA |
 |
STERIS plc
STE
|
1.02 B | $ 213.97 | -0.93 % | $ 21.1 B | USA |
 |
Teleflex Incorporated
TFX
|
762 M | $ 130.2 | -0.06 % | $ 5.81 B | USA |
 |
InfuSystem Holdings
INFU
|
20.2 M | $ 8.76 | 1.74 % | $ 181 M | USA |
 |
Microbot Medical
MBOT
|
3.42 M | $ 1.9 | 2.43 % | $ 87 M |  Israel |
 |
Milestone Scientific
MLSS
|
4.13 M | $ 0.34 | 0.16 % | $ 27.9 M | USA |
 |
Merit Medical Systems
MMSI
|
240 M | $ 62.28 | -0.45 % | $ 3.68 B | USA |
 |
Utah Medical Products
UTMD
|
2.6 M | $ 63.27 | -0.68 % | $ 205 M | USA |
 |
West Pharmaceutical Services
WST
|
655 M | $ 301.5 | 0.44 % | $ 21.8 B | USA |
 |
Pulse Biosciences
PLSE
|
7.92 M | $ 24.13 | -10.96 % | $ 1.63 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.34 B | $ 10.04 | -3.6 % | $ 2 B | USA |
 |
Retractable Technologies
RVP
|
9.6 M | $ 0.69 | - | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
14.6 M | $ 59.84 | 2.03 % | $ 197 M | USA |
 |
Predictive Oncology
POAI
|
4.27 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
23 M | $ 20.6 | -2.18 % | $ 984 M | USA |
 |
Stereotaxis
STXS
|
22.4 M | $ 1.88 | -3.35 % | $ 171 M | USA |
 |
Baxter International
BAX
|
2.97 B | $ 17.39 | -2.19 % | $ 8.92 B | USA |
 |
ResMed
RMD
|
689 M | $ 203.3 | 0.41 % | $ 29.7 B | USA |
 |
AtriCure
ATRC
|
81.5 M | $ 28.16 | 0.02 % | $ 1.34 B | USA |
 |
Harvard Bioscience
HBIO
|
22 M | $ 5.34 | -3.26 % | $ 237 M | USA |
 |
NeuroMetrix
NURO
|
1.01 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
76.2 M | - | - | $ 447 M | USA |
 |
Becton, Dickinson and Company
BDX
|
8.31 B | $ 142.86 | -1.11 % | $ 41.1 B | USA |
 |
Nephros
NEPH
|
2.77 M | $ 3.13 | -6.29 % | $ 33.2 M | USA |
 |
OraSure Technologies
OSUR
|
39.8 M | $ 3.12 | 5.76 % | $ 229 M | USA |
 |
Repligen Corporation
RGEN
|
136 M | $ 106.52 | 3.03 % | $ 5.99 M | USA |